• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    11/14/24 4:11:11 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care
    Get the next $HLF alert in real time by email
    SC 13G/A 1 o1028244sc13ga2.htm AMENDMENT NO. 2

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G/A

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

     

    HERBALIFE NUTRITION LTD.
    (Name of Issuer)
     
    Common Shares, $0.0005 Par Value
    (Title of Class of Securities)

     

      G4412G101  
      (CUSIP Number)  
     
    September 30, 2024
    (Date of Event Which Requires Filing of This Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      x Rule 13d-1(b)
         
      o Rule 13d-1(c)
         
      o Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     Page 1 of 8 pages 
     

     

    CUSIP No. G4412G101
    1

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    The WindAcre Partnership LLC

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     

     

    (a) o

    (b) o

    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH REPORTING

    PERSON WITH:

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    7,969,053

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    7,969,053

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    7,969,053

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

     

    o

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    7.91%

    12

    TYPE OF REPORTING PERSON (see instructions)

     

    IA

     

     Page 2 of 8 pages 
     

     

    CUSIP No. G4412G101
    1

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    The WindAcre Partnership Master Fund, LP

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     

     

    (a) o

    (b) o

    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH REPORTING

    PERSON WITH:

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    7,969,053

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    7,969,053

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    7,969,053

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

     

    o

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    7.91%

    12

    TYPE OF REPORTING PERSON (see instructions)

     

    PN

     

     Page 3 of 8 pages 
     

     

    CUSIP No. G4412G101
    1

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Snehal Rajnikant Amin

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

     

     

    (a) o

    (b) o

    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    USA

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH REPORTING

    PERSON WITH:

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    7,969,053

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    7,969,053

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    7,969,053

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions)

     

    o

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    7.91%

    12

    TYPE OF REPORTING PERSON (see instructions)

     

    IN

     

     Page 4 of 8 pages 
     

     

    Item 1(a). Name of Issuer:
       
       Herbalife Nutrition LTD. (the “Issuer”)
       
    Item 1(b). Address of Issuer’s Principal Executive Offices:
       
      

    P.O. Box 309

    Ugland House

    Grand Cayman

    Cayman Islands

       
    Item 2(a). Name of Person Filing:
       
      

    This statement is being jointly filed by:

    ·     The WindAcre Partnership LLC, a Delaware limited liability company, (“WindAcre”)

    ·     The WindAcre Partnership Master Fund LP, an exempted limited partnership established in the Cayman Islands (“Master Fund”)

    ·     Snehal Rajnikant Amin, as the principal beneficial owner of The WindAcre Partnership LLC and the only beneficial owner holding more than 5% (“Mr. Amin”).

     

    Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.”

     

    WindAcre serves as the investment manager of the Master Fund. Mr. Amin is the managing member of WindAcre. By virtue of these relationships, each of WindAcre and Mr. Amin may be deemed to beneficially own the Issuer’s Common Shares directly owned by the Master Fund.

       
    Item 2(b). Address of Principal Business Office or, if none, Residence:
         
      

    The principal business address of WindAcre is 2200 Post Oak Blvd., Suite 1580, Houston, Texas 77056.

    The principal business address of the Master Fund is Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay,

    Grand Cayman KY1-9009, Cayman Islands.

       
    Item 2(c). Citizenship:
       
      

    Mr. Amin is a citizen of the United States of America.

     

    WindAcre is a limited liability company formed under the laws of the State of Delaware.

     

    The Master Fund is an exempted company formed under the laws of the Cayman Islands.

       
    Item 2(d). Title of Class of Securities:
       
       Common Shares, $0.0005 par value per share (“Common Shares” or “Shares”)
       
    Item 2(e). CUSIP Number:  G4412G101

     

    Item 3. If this Statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
      (a) o Broker or dealer registered under Section 15 of the Act;
      (b) o Bank as defined in Section 3(a)(6) of the Act;
      (c) o Insurance company as defined in Section 3(a)(19) of the Act;
      (d) o Investment company registered under Section 8 of the Investment Company Act of 1940;
      (e) x An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
      (f) o An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
      (g) o A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
      (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
      (j) o A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
      (k) o Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:      

     

     Page 5 of 8 pages 
     

     

    Item 4. Ownership.
      Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
       (a)

    Amount Beneficially Owned:

     

    The Master Fund owns 7,969,053 Shares of Common Stock, consisting of 7,969,053 Shares of Class A Common Stock directly held. By virtue of their relationships with the Master Fund discussed in further detail in Item 2, each of WindAcre and Mr. Amin may be deemed to beneficially own the Shares owned by the Master Fund.

     

    This Schedule 13G reports an aggregate of 7,969,053 Shares of Class A Common Stock, consisting of 7,969,053 Shares of Class A Common Stock directly held. The filing of this Schedule 13G shall not be construed as an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any of the Shares reported herein. Each of the Reporting Persons specifically disclaims beneficial ownership of the Shares reported herein that are not directly owned by such Reporting Person.

       
           
       (b)

    Percent of Class:

     

    The following ownership percentages are based on 100,717,737 Shares outstanding, which is comprised of 100,717,737 Shares of Class A Common Stock outstanding as of July 24, 2024, as reported in the Issuer’s Form 10-Q dated July 31, 2024.

     

    The 7,969,053 Shares owned by the Master Fund represent approximately 7.91% of the outstanding Shares. By virtue of its relationship with the Master Fund discussed in further detail in Item 2, WindAcre may be deemed to beneficially own 7,969,053, representing approximately 7.91% of the outstanding Shares and Mr. Amin may be deemed to beneficially own 7,969,053 Shares representing approximately 7.91% of the outstanding Shares.

     

    This schedule 13G reports an aggregate of 7,969,053 Shares, representing approximately 7.91% of the outstanding Shares.

     
           
       (c) Number of shares as to which such person has:
          (i)

    sole power to vote or to direct the vote:

     

    []

       
             
          (ii)

    shared power to vote or to direct the vote:

     

    The Master Fund, WindAcre and Mr. Amin share the power to vote or direct the vote of the 7,969,053 Shares owned by the Master Fund.

       
             
          (iii)

    sole power to dispose or to direct the disposition of:

     

    []

       
             
          (iv)

    shared power to dispose or to direct the disposition of:

     

    The Master Fund, WindAcre, and Mr. Amin share the power to dispose or direct the disposition of the 7,969,053 Shares owned by the Master Fund.

       

     

     Page 6 of 8 pages 
     

     

    Item 5. Ownership of Five Percent or Less of a Class.
       
       If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
       
       Not applicable.
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
       
       Not applicable.
       
    Item 8. Identification and Classification of Members of the Group.
       
       Not applicable.
       
    Item 9. Notice of Dissolution of Group.
       
       Not applicable.
       
    Item 10. Certification.
       
       By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of and do not have the effect of changing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect for the time being.

     

     Page 7 of 8 pages 
     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: November 14, 2024 The WindAcre Partnership Master Fund LP
       
       
      By: The WindAcre Partnership LLC
        As Investment Manager
       
       
      By: /s/ Snehal Amin
        Name: Snehal Amin
        Title: Managing Member of the Investment Manager

     

     

    Page 8 of 8 pages

     

     

     

    Get the next $HLF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HLF

    DatePrice TargetRatingAnalyst
    3/21/2025$7.50 → $14.00Neutral → Buy
    DA Davidson
    8/1/2024$16.00 → $17.00Buy
    B. Riley Securities
    9/14/2023$13.50Neutral
    DA Davidson
    6/7/2023$13.00Neutral
    Mizuho
    2/3/2023$14.00Underperform
    BofA Securities
    7/12/2022$26.00Hold → Buy
    Jefferies
    5/17/2022Buy → Hold
    Argus
    5/4/2022$60.00 → $26.00Buy → Hold
    Jefferies
    More analyst ratings

    $HLF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Herbalife's Aloin Identification Method for Aloe Vera Officially Recognized by AOAC INTERNATIONAL

      Certified Method Enhances Global Botanical Quality and Safety Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the Association of Official Analytical Collaboration (AOAC INTERNATIONAL)—a global authority in analytical science—has formally certified its proprietary method for identifying and measuring anthraquinones, also known as aloins, in aloe vera. Aloe regulatory groups require producers of ingestible aloe vera products to monitor naturally occurring compounds such as aloin A, aloin B, and aloe-emodin to meet safety guidelines. This certification officially recognizes Herbalife's longstanding method as the world's first AOAC-app

      6/11/25 7:14:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Participate in MicroCap Rodeo Conference on June 4

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, will participate in a fireside chat at the MicroCap Rodeo Conference on Wednesday, June 4, 2025 at 9:30 a.m. ET (6:30 a.m. PT). The webcast will be available at the following link: https://www.webcaster4.com/Webcast/Page/3119/52530 The webcast will also be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay of the webcast will be available at the same website following the completion of the event and for six months thereafter. For more details about the MicroCap Rodeo Conference in New

      5/27/25 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Reports Q1 Net Sales at Midpoint of Guidance Range, Net Sales Growth Excluding FX Headwinds1; Q1 Adjusted EBITDA2 Exceeds Guidance; Updates Full-Year Guidance

      Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430667438/en/ "Our first quarter results were strong, and we raised our full-year 2025 Adjusted EBITDA2 expectations. Our recent acquisitions strengthen our position and support our commitment to transformative growth," Stephan Gratziani, President and incoming CEO (effective May 1 '25). Highlights First Quarter 2025 Net sales of $1.2 billion at midpoint of guidance range Down 3.4% vs. Q1 ‘24 Includes 480 basis points of FX headwinds Up 1.4% year-over-year on constant cu

      4/30/25 4:10:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    $HLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      6/9/25 6:00:12 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/23/25 4:01:25 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $33,650 worth of shares (5,000 units at $6.73) and was granted 21,857 shares, increasing direct ownership by 20% to 161,857 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/6/25 8:19:33 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    $HLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      6/9/25 6:00:12 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

      4 - HERBALIFE LTD. (0001180262) (Issuer)

      5/23/25 4:01:25 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • New insider Levy Robert claimed ownership of 449,358 shares (SEC Form 3)

      3 - HERBALIFE LTD. (0001180262) (Issuer)

      5/12/25 7:39:33 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    $HLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Herbalife Nutrition upgraded by DA Davidson with a new price target

      DA Davidson upgraded Herbalife Nutrition from Neutral to Buy and set a new price target of $14.00 from $7.50 previously

      3/21/25 8:38:07 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • B. Riley Securities reiterated coverage on Herbalife Nutrition with a new price target

      B. Riley Securities reiterated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $17.00 from $16.00 previously

      8/1/24 8:12:23 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • DA Davidson initiated coverage on Herbalife Nutrition with a new price target

      DA Davidson initiated coverage of Herbalife Nutrition with a rating of Neutral and set a new price target of $13.50

      9/14/23 7:19:53 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care

    $HLF
    SEC Filings

    See more

    $HLF
    Financials

    Live finance-specific insights

    See more

    $HLF
    Leadership Updates

    Live Leadership Updates

    See more

    $HLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - HERBALIFE LTD. (0001180262) (Filer)

      4/30/25 4:40:01 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-Q filed by Herbalife Ltd.

      10-Q - HERBALIFE LTD. (0001180262) (Filer)

      4/30/25 4:16:43 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Herbalife Ltd.

      SCHEDULE 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      4/30/25 11:12:30 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Reports Q1 Net Sales at Midpoint of Guidance Range, Net Sales Growth Excluding FX Headwinds1; Q1 Adjusted EBITDA2 Exceeds Guidance; Updates Full-Year Guidance

      Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430667438/en/ "Our first quarter results were strong, and we raised our full-year 2025 Adjusted EBITDA2 expectations. Our recent acquisitions strengthen our position and support our commitment to transformative growth," Stephan Gratziani, President and incoming CEO (effective May 1 '25). Highlights First Quarter 2025 Net sales of $1.2 billion at midpoint of guidance range Down 3.4% vs. Q1 ‘24 Includes 480 basis points of FX headwinds Up 1.4% year-over-year on constant cu

      4/30/25 4:10:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife to Announce First Quarter 2025 Results on April 30

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its first quarter 2025 financial results after the close of trading on the NYSE on Wednesday, April 30, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/bd8j8th6 Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BI1210

      4/1/25 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Reports Q4 Net Sales at High End of Guidance, Q4 and Full-Year Net Sales Growth Excluding FX Headwinds1; Q4 Adjusted EBITDA2 Exceeds Guidance

      Stephan Gratziani Appointed CEO; Michael Johnson Named Executive Chairman Herbalife Ltd. (NYSE:HLF) today reported financial results for the fourth quarter and year ended December 31, 2024: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219267078/en/ "With three consecutive quarters of new distributor growth, a new incoming CEO and significantly improved Adjusted EBITDA2 margins, we enter 2025 with strong momentum." - Michael Johnson, Chairman and CEO Highlights Fourth Quarter 2024 Net sales of $1.2 billion, down 0.6% vs. Q4 '23 and at high end of guidance range Includes 330 basis points of FX headwinds Up 2.7% year-o

      2/19/25 4:10:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Welcomes Lynda Cloud to its Board of Directors

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

      4/25/25 5:12:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Appoints Stephan Gratziani as Chief Executive Officer

      Current CEO Michael Johnson Transitions to Executive Chairman Herbalife Ltd. (NYSE:HLF) today announced its Board of Directors has appointed President, Stephan Gratziani as Chief Executive Officer (CEO) effective May 1, 2025. Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219653469/en/Herbalife appoints Stephan Gratziani as Chief Executive Officer (Photo: Business Wire) As a former Herbalife independent distributor, Mr. Gratziani built and grew his international business into one of the top global distributorships. For 32 years, he

      2/19/25 4:05:00 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Herbalife Expands Board of Directors with Appointment of Perkins Miller

      Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today welcomed experienced e-commerce and media technology executive Perkins Miller to its board of directors. Miller's appointment as an independent director is effective June 26, 2024. "Perkins brings valuable, proven expertise in leading large-scale e-commerce, technology and sports enterprises, which will be a great asset to our Board as the Company continues to grow and transform," said Michael Johnson, Chairman and CEO of Herbalife. Miller is the CEO of Fandom, the world's largest fan platform where fans immerse themselves in imagined worlds across entertainment and gaming, where he has trans

      6/26/24 7:05:00 AM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      11/14/24 4:11:11 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G filed by Herbalife Ltd.

      SC 13G - HERBALIFE LTD. (0001180262) (Subject)

      11/13/24 4:01:31 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

      SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

      11/13/24 12:49:27 PM ET
      $HLF
      Other Pharmaceuticals
      Health Care